MED.UNIV-RENNES1.FR : www.med.univ-rennes1.fr - 15 in TOP 100 MEDICAL SITES. Rating: 260000.

Most popular searches: enseignement, campus numérique, www.med.univ-rennes1.r, Nachrichten, Allergy, médical, www.med.uni-rennes1.fr, blood pressure, Immunology, www.med.univ-renns1.fr, www.med.univ-rennes1.com, family practice, ww.med.univ-rennes1.fr, wwwmed.univ-rennes1.fr, informatique, www.meduniv-rennes1.fr, patient, www.ed.univ-rennes1.fr, www.med.univ-renne1.fr, obesity, medical information, connaissances, www.md.univ-rennes1.fr, health care, www.med.uiv-rennes1.fr, Pharmaceutical, médecine, médicale, drug rehab, Cardiac, asthma, www.med.univrennes1.fr, drug, www.med.univ-rnnes1.fr, health, Krankenhaus, laboratoire, ww.med.univ-rennes1.fr, www.med.univ-rennes1.fr, physician, wwwmed.univ-rennes1.fr, www.med.univ-ennes1.fr, serveurs, information, université virtuelle, genome, www.med.niv-rennes1.fr, www.med.univ-rennes1fr, cholesterol, medicine, medical research, doctor, vaccines, www.med.univ-rennes1.f, www.med.univ-renes1.fr, www.med.univ-rennes.fr, www.me.univ-rennes1.fr, www.med.unv-rennes1.fr, LIM

PPD Names Deborah Covington as Global Head of Observational Studies and Pregnancy Registries (Business Wire)
WILMINGTON, N.C.----PPD, Inc. today announced the appointment of Deborah Covington, Dr.PH., as global head of observational studies and pregnancy registries. In this role, she will provide leadership and direction to the companyÃ¢Â€Â™s late stage group and serve as a member of the strategic and scientific advisory team.
us.rd.yahoo.com

NeoStem Moves Ahead with China Biopharma Acquisition
ChinaBio Today submits: NeoStem, Inc. (NBS) reported the SEC accepted its registration proposal to acquire China Biopharmaceutical Holdings (CHBP.OB) in an all-stock transaction. China Biopharma’s only asset is a 51% interest in Suzhou Erye Pharmaceutical Co., a generic drug manufacturer that in 2008 produced $50 million in revenues and net income of $8 million. The next step is for stockholders in both companies to vote on the merger, which is scheduled for later this month.NeoStem claims a nominal business in US-based adult stem cell storage. However, that business generated just $630,000 of revenue last year, while the company’s expenses were close to $12 million. NeoStem has put together a number of different stem cell programs, which it plans to advance in China. These include:Complete Story »
seekingalpha.com

Heat Device Treats Asthma
An FDA panel recommended that the agency approve a first-of-kind device to treat severe asthma patients.
online.barrons.com

Pfizer Adds New Tablet to Sales Calls
Pfizer is equipping its sales representatives with new portable computers designed to improve their pitches to doctors—and at the same time help the drug maker comply with the law.
online.wsj.com

Cord Blood America Announces $6 Million in Notes Retired (PR Newswire)
Cord Blood America, Inc. , the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, today said that it has retired almost $6 million worth of notes which had been provided by Enable Capital Management, LLC and their affiliates between 2007 and 2009.
us.rd.yahoo.com